Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market. The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others). The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report "Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)", global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 - 2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.

The report titled "Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)" has covered and analyzed the potential of Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Nuclear Medicine Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
• Global Nuclear Medicine Market - Size, Growth, Forecast
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Regional Markets - North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Nuclear Medicine Market - Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil)
• Nuclear Medicine Market - Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)

Other Report Highlights
• Market Dynamics - Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Competitive Landscape
• Company Analysis - Bracco Imaging, Lantheus Holding, Curium, Jubilant Lifesciences, 3B Pharmaceutical Cardinal Health Advanced Accelerator Application, Eckert & Ziegler

Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research. 


Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Nuclear Medicine Market Overview

5. Global Nuclear Medicine : Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Nuclear Medicine Market: By Indication
6.1 Global  Nuclear Medicine Market-By Product Type: Breakdown(%)
6.1.1 Global Nuclear Medicine Market  Size and Share, By Product Type, 2017
6.1.2 Global Nuclear Medicine Market  Size and Share, By Product Type, 2023
6.2 Global Diagnostic Nuclear Medicine Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Therapeutic  Nuclear Medicine Market Overview
6.3.1 By Value (2013-2023)

7 Global Nuclear Medicine Market: By Therapeutic Type 
7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%)
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023
7.2 Global  Beta Emitters Nuclear Medicine Market Overview
7.2.1 By Value (2013-2023)
7.3 Global Alpha Emitters Nuclear Medicine Market Overview
7.3.1 By Value (2013-2023)
7.4 Global Brachytherapy Nuclear Medicine Market Overview
7.4.1 By Value (2013-2023)

8 Global Nuclear Medicine Market :By Diagnostic  Type
8.1 Global Nuclear Medicine Market :By Diagnostic  Type: Breakdown(%)
8.1.1 Global Nuclear Medicine Market :By Diagnostic  Type, 2017
8.1.2 Global Nuclear Medicine Market :By Diagnostic  Type, 2023
8.2 Global SPECT Nuclear Medicine Market Overview
8.2.1 By Value (2013-2023)
8.3 Global PET Nuclear Medicine Market Overview
8.3.1 By Value (2013-2023)

9. Global Nuclear Medicine Market :By Indication
9.1 Global Nuclear Medicine Market :By Indication: Breakdown(%)
9.1.1 Global  Nuclear Medicine Market :Indication, 2017
9.1.2 Global  Nuclear Medicine Market :Indication, 2023
9.2 Global Nuclear Medicine For Oncological Disorders Market
9.2.1 By Value (2013-2023)
9.3 Global Nuclear Medicine For Cardiovascular Disorders Market
9.3.1 By Value (2013-2023)
9.4  Global Nuclear Medicine For Neurological Disorders Market
9.4.1 By Value (2013-2023)
9.5  Global Nuclear Medicine For Other Disorders Market
9.5.1 By Value (2013-2023)

10. Global Nuclear Medicine Market: Regional Analysis                                                                                                  
10.1 Global Nuclear Medicine Market, By Region: Breakdown (%)                                                                     
10.1.1 Global  Nuclear Medicine Market Size, By Region, 2017 (%)                                                     
10.1.2 Global  Nuclear Medicine Market Size, By Region, 2023 (%)  
                                                   
10.2 North America Nuclear Medicine Market: An Analysis                                                                                
10.2.1 By Value (2013-2017)
10.2.2 By Value (2018-2023)

10.3 North America  Nuclear Medicine Market: Segment Analysis
10.3.1 North America  Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.3.2 North America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.3.3 North America  Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.3.4 North America  Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.4.1 U.S. Nuclear Medicine Market, By Value (2013-2023)
10.4.1.1 U.S. Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.4.2 Canada Nuclear Medicine Market, By Value (2013-2023)
10.4.2.1 Canada Nuclear Medicine Market, By Indication, By Value (2013-2023)

10.5 Europe Nuclear Medicine Market: An Analysis
10.5.1 By Value (2013-2017)
10.5.2 By Value (2018-2023)

10.6 Europe Nuclear Medicine Market: Segment Analysis
10.6.1 Europe Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.6.2 Europe America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.6.3 Europe Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.6.4 Europe Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe)
10.7.1 Germany Nuclear Medicine Market, By Value (2013-2023)
10.7.1.1 Germany Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.7.2 France  Nuclear Medicine Market, By Value (2013-2023)
10.7.2.1 France Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.7.3 Rest of Europe  Nuclear Medicine Market, By Value (2013-2023)

10.8 Asia Pacific Nuclear Medicine Market: An Analysis
10.8.1 By Value (2013-2017)
10.8.2 By Value (2018-2023)

10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis
10.9.1 Asia Pacific Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.9.2 Asia Pacific   America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.9.3 Asia Pacific Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.9.4 Asia Pacific Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.10 Asia Pacific  Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
10.10.1 China Nuclear Medicine Market, By Value (2013-2023)
10.10.1.1 China  Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.2 Japan Nuclear Medicine Market, By Value (2013-2023)
10.10.2.1 Japan Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.3 India Nuclear Medicine Market, By Value (2013-2023)
10.10.3.1 India Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.4 Rest of Asia Pacific  Nuclear Medicine Market, By Value (2013-2023)

10.11 Rest of World Nuclear Medicine Market: An Analysis
10.11.1 By Value (2013-2017)
10.11.2 By Value (2018-2023)

10.12 Rest of World Nuclear Medicine Market: Segment Analysis
10.12.1 Rest of World Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.12.2 Rest of World Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.12.3 Rest of World Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.12.4 Rest of World Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others)
10.13.1 Brazil Nuclear Medicine Market, By Value (2013-2023)
10.13.1 Brazil  Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.13.2 Others Nuclear Medicine Market, By Value (2013-2023)

11. Market Dynamics
11.1 Drivers
11.2 Challenges

12. Market Trends

13. Porter's Five Forces Analysis -Nuclear Medicine Market  
                                                                                              
14. SWOT Analysis -Nuclear Medicine Market 

15. Supply Chain Analysis Nuclear Medicine Market

16. Policy and Regulatory Landscape

17. Competitive Landscape

18. Company Profiles
18.1 Eckert & Ziegler
18.2 Advanced Accelerator Applications
18.3 Cardinal Health
18.4 3B Pharmaceuticals
18.5 Jubilant Life Sciences
18.6 Curium
18.7 Lantheus Holdings
18.8 Bracco Imaging
Manufacturing and Construction

Nuclear Plant Operations and Maintenance Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

  Price : US$ 3,500   Date : Nov 2024
  Category : Manufacturing and Construction   Pages : 116
Healthcare and Pharmaceuticals

Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 191
Healthcare and Pharmaceuticals

Europe Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 196
Healthcare and Pharmaceuticals

North America Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,450   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 194
Healthcare and Pharmaceuticals

Global Nuclear Medicine Market Size, Share, Trends & Analysis by Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others) and Region, with Forecasts from 2024 to 2034.

  Price : US$ 3,750   Date : Oct 2024
  Category : Healthcare and Pharmaceuticals   Pages : 205

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Nuclear Plant Operations And Maintenance Services Market Size And Share Analysis - Growth Tre...
View More
Asia Pacific Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (...
View More
Europe Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT,...
View More
North America Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics ...
View More
Global Nuclear Medicine Market Size, Share, Trends & Analysis By Product (Diagnostics (SPECT,...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved